352 related articles for article (PubMed ID: 19502584)
41. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.
Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C
J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354
[TBL] [Abstract][Full Text] [Related]
42. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.
O'Keefe GM; Nguyen VT; Benveniste EN
Eur J Immunol; 1999 Apr; 29(4):1275-85. PubMed ID: 10229095
[TBL] [Abstract][Full Text] [Related]
43. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
[TBL] [Abstract][Full Text] [Related]
44. Tyk2 is essential for IFN-alpha-induced gene expression in mast cells.
Mori Y; Hirose K; Suzuki K; Nakajima H; Seto Y; Ikeda K; Shimoda K; Nakayama K; Saito Y; Iwamoto I
Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():25-9. PubMed ID: 15166480
[TBL] [Abstract][Full Text] [Related]
45. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
Pai RK; Askew D; Boom WH; Harding CV
J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955
[TBL] [Abstract][Full Text] [Related]
46. A study of mast cells in autoimmune mice: the proliferative response of autoimmune mast cells to cytokines.
Ohmori J
Autoimmunity; 1994; 17(4):279-85. PubMed ID: 7524705
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
[TBL] [Abstract][Full Text] [Related]
48. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
Tooze RM; Stephenson S; Doody GM
J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
[TBL] [Abstract][Full Text] [Related]
49. Evidence for the in vivo role of class II transactivator in basal and IFN-gamma induced class II expression in mouse tissue.
Ramassar V; Goes N; Hobart M; Halloran PF
Transplantation; 1996 Dec; 62(12):1901-7. PubMed ID: 8990384
[TBL] [Abstract][Full Text] [Related]
50. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
51. Trib3 is regulated by IL-3 and affects bone marrow-derived mast cell survival and function.
Ord T; Ord D; Kuuse S; Plaas M; Ord T
Cell Immunol; 2012 Nov; 280(1):68-75. PubMed ID: 23261831
[TBL] [Abstract][Full Text] [Related]
52. [The expression and significance of major histocompatibility complex II transactivator gene in five human malignant hematological cell lines].
You Y; Zou P; Guo R
Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):288-91. PubMed ID: 15130416
[TBL] [Abstract][Full Text] [Related]
53. Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation.
Gupta AA; Leal-Berumen I; Croitoru K; Marshall JS
J Immunol; 1996 Sep; 157(5):2123-8. PubMed ID: 8757336
[TBL] [Abstract][Full Text] [Related]
54. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.
Tang KC; Trzaska KA; Smirnov SV; Kotenko SV; Schwander SK; Ellner JJ; Rameshwar P
J Immunol; 2008 Feb; 180(3):1826-33. PubMed ID: 18209080
[TBL] [Abstract][Full Text] [Related]
55. PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
Yashiro T; Kubo M; Ogawa H; Okumura K; Nishiyama C
PLoS One; 2015; 10(9):e0137699. PubMed ID: 26361334
[TBL] [Abstract][Full Text] [Related]
56. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
57. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
[TBL] [Abstract][Full Text] [Related]
58. Differential usage of class II transactivator promoters PI and PIV during inflammation and injury in kidney.
Takeuchi O; Sims TN; Takei Y; Ramassar V; Famulski KS; Halloran PF
J Am Soc Nephrol; 2003 Nov; 14(11):2823-32. PubMed ID: 14569092
[TBL] [Abstract][Full Text] [Related]
59. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression.
Morris AC; Riley JL; Fleming WH; Boss JM
Am J Reprod Immunol; 1998 Dec; 40(6):385-94. PubMed ID: 9894561
[TBL] [Abstract][Full Text] [Related]
60. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
van der Stoep N; Biesta P; Quinten E; van den Elsen PJ
Int J Cancer; 2002 Feb; 97(4):501-7. PubMed ID: 11802213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]